# 68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

> **NCT02666547** · PHASE1 · TERMINATED · sponsor: **University of Lausanne Hospitals** · enrollment: 42 (actual)

## Conditions studied

- Pathological Angiogenesis

## Interventions

- **DRUG:** 68Ga-NODAGA-RGD PET/CT
- **RADIATION:** 18F-FDG PET/CT
- **RADIATION:** 18F-FET PET/CT

## Key facts

- **NCT ID:** NCT02666547
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2023-08
- **Final completion:** 2023-09
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** lack of resources
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666547, "68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02666547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*